Mapping the Clinical and Multi-Omics Terrain to New Horizons in Inflammatory Bowel Disease
Grand Rounds
Department of Medicine Grand Rounds
-
Crohn’s disease and ulcerative colitis (UC) have seen sweeping changes and novel therapeutic approaches. In this Department of Medicine Grand Rounds, we will discuss different therapeutic approaches to these inflammatory bowel diseases (IBD) with a specific focus on the innovative uses of JAK inhibitors in UC and Crohn’s. Our speakers’ insights will take us from the bench to the bedside, including a focus on the impact of diet in the development and management of IBD.
Speakers
Kendall Beck, MD, is an associate professor and medical director of Ambulatory Gastroenterology in the Division of Gastroenterology at UCSF Health. She earned her MD from the University of Texas Health Science Center at Houston and then completed both a residency in internal medicine and a fellowship in gastroenterology at UCSF. She is a renowned clinician-educator, with a particular interest in the care of patients with IBD.
Michael Kattah, MD, PhD, is an assistant professor in the Division of Gastroenterology at UCSF Health. Clinically, he specializes in treating IBD patients and those with immune checkpoint inhibitor-induced colitis. A physician-scientist, he obtained his PhD in Immunology from Stanford and completed his GI fellowship at UCSF. His laboratory focuses on developing precision medicine approaches to managing IBD as well as identifying less toxic therapies. He received a New Innovator award from the Rainin Foundation, and has received several career development awards.
How to Attend
In Person:
N-217 (Nursing Building, enter through 521 Parnassus Avenue.)
Lunch will be provided.
Add to Calendar2023-10-19 19:00:002023-10-19 20:00:00Mapping the Clinical and Multi-Omics Terrain to New Horizons in Inflammatory Bowel Disease
Crohn’s disease and ulcerative colitis (UC) have seen sweeping changes and novel therapeutic approaches. In this Department of Medicine Grand Rounds, we will discuss different therapeutic approaches to these inflammatory bowel diseases (IBD) with a specific focus on the innovative uses of JAK inhibitors in UC and Crohn’s. Our speakers’ insights will take us from the bench to the bedside, including a focus on the impact of diet in the development and management of IBD.
Speakers
Kendall Beck, MD, is an associate professor and medical director of Ambulatory Gastroenterology in the Division of Gastroenterology at UCSF Health. She earned her MD from the University of Texas Health Science Center at Houston and then completed both a residency in internal medicine and a fellowship in gastroenterology at UCSF. She is a renowned clinician-educator, with a particular interest in the care of patients with IBD.
Michael Kattah, MD, PhD, is an assistant professor in the Division of Gastroenterology at UCSF Health. Clinically, he specializes in treating IBD patients and those with immune checkpoint inhibitor-induced colitis. A physician-scientist, he obtained his PhD in Immunology from Stanford and completed his GI fellowship at UCSF. His laboratory focuses on developing precision medicine approaches to managing IBD as well as identifying less toxic therapies. He received a New Innovator award from the Rainin Foundation, and has received several career development awards.
How to Attend
In Person:
N-217 (Nursing Building, enter through 521 Parnassus Avenue.)
Lunch will be provided.
On Zoom:
Join from a PC, Mac, iPad, iPhone or Android device:
https://ucsf.zoom.us/j/93868706312?pwd=ZWpzeHlNYmJzcUp3c1JxRWpyTGF2QT09
Webinar ID: 938 6870 6312
Passcode: 249803
By Phone (for higher quality, dial a number based on your current location):
US: +1 669 900 6833 or +1 346 248 7799 or +1 312 626 6799 or
+1 646 558 8656 or +1 253 215 8782 or +1 301 715 8592
International numbers available: https://ucsf.zoom.us/u/abBh6VatYU
The session will be recorded for later play. See all past recordings.
[email protected], [email protected]GastroenterologyAmerica/Los_Angelespublic
